Cargando…

Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center

Dalbavancin is a lipoglycopeptide approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The aim of the study was to evaluate the efficacy and safety in all patients who received at least one administration of dalbavancin. Methods: We carried out a retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brescini, Lucia, Della Martera, Filippo, Morroni, Gianluca, Mazzanti, Sara, Di Pietrantonio, Maria, Mantini, Paolo, Candelaresi, Bianca, Pallotta, Francesco, Olivieri, Silvia, Iencinella, Valentina, Castelletti, Sefora, Cocci, Emanuele, Polo, Rosaria G., Veccia, Salvatore, Cirioni, Oscar, Tavio, Marcello, Giacometti, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468778/ https://www.ncbi.nlm.nih.gov/pubmed/34572711 http://dx.doi.org/10.3390/antibiotics10091129

Ejemplares similares

Ceftazidime–Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study
por: Di Pietrantonio, Maria, et al.
Publicado: (2022)

Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study
por: Pasquini, Zeno, et al.
Publicado: (2021)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

In Vitro Activity of Novel Lipopeptides against Triazole-Resistant Aspergillus fumigatus
por: Fioriti, Simona, et al.
Publicado: (2022)

Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy
por: Brescini, Lucia, et al.
Publicado: (2019)

Witch Hazel Significantly Improves the Efficacy of Commercially Available Teat Dips
por: Rasooly, Reuven, et al.
Publicado: (2020)

whISOBAX(TM) Inhibits Bacterial Pathogenesis and Enhances the Effect of Antibiotics
por: Rasooly, Reuven, et al.
Publicado: (2020)

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
por: Simonetti, Oriana, et al.
Publicado: (2021)

Candidemia in Internal Medicine: Facing the New Challenge
por: Brescini, Lucia, et al.
Publicado: (2022)

Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
por: Morroni, Gianluca, et al.
Publicado: (2021)

Antifungal Combinations against Candida Species: From Bench to Bedside
por: Fioriti, Simona, et al.
Publicado: (2022)

Candidemia in intensive care units over nine years at a large Italian university hospital: Comparison with other wards
por: Mazzanti, Sara, et al.
Publicado: (2021)

MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience
por: Piccica, Matteo, et al.
Publicado: (2023)

Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience
por: Mazzitelli, Maria, et al.
Publicado: (2021)

Dalbavancin: a novel antimicrobial
por: Chen, A Y, et al.
Publicado: (2007)

Antifungal Combinations in Dermatophytes
por: Brescini, Lucia, et al.
Publicado: (2021)

Dalbavancin Boosts the Ability of Neutrophils to Fight Methicillin-Resistant Staphylococcus aureus
por: Scutera, Sara, et al.
Publicado: (2023)

267 Dalbavancin for the treatment of Streptococcal Skin Infections
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

Successful Treatment of Diabetic Foot Osteomyelitis with Dalbavancin
por: Loupa, Chariclia V., et al.
Publicado: (2020)

Dalbavancin: novel candidate for COVID-19 treatment
por: Hoffmann, Markus, et al.
Publicado: (2021)

Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2022)

Global trends of dalbavancin: A bibliometric analysis
por: Monteagudo‐Martínez, Nuria, et al.
Publicado: (2022)

Dalbavancin for Staphylococcus aureus Bacteremia: Are We There Yet?
por: Mahatanan, Rattanaporn, et al.
Publicado: (2023)

2902. Dalbavancin Use in Bone and Joint Infections
por: Sanikommu, Srivani, et al.
Publicado: (2023)

2764. Experience with dalbavancin in a pediatric hospital
por: Leon, Maria Deza, et al.
Publicado: (2023)

Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches
por: Tortorano, Anna Maria, et al.
Publicado: (2021)

Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals
por: Bai, Francesca, et al.
Publicado: (2023)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
por: Simonetti, Oriana, et al.
Publicado: (2021)

Dalbavancin Population Pharmacokinetic Modeling and Target Attainment Analysis
por: Carrothers, Timothy J., et al.
Publicado: (2019)

1268. Dalbavancin for the Treatment of Infections due to Staphylococcus aureus
por: Streifel, Amber C, et al.
Publicado: (2020)

122. Dalbavancin Use in Patients with Substance Use Disorders
por: Streifel, Amber C, et al.
Publicado: (2020)

Use of dalbavancin in infective endocarditis: a case series
por: Guleri, Achyut, et al.
Publicado: (2021)

614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021)

1004. Dalbavancin Use and Associated Cost-Savings: An Update
por: Streifel, Amber C, et al.
Publicado: (2022)

Dalbavancin in Bone and Joint Infections: A Systematic Review
por: Lovatti, Sofia, et al.
Publicado: (2023)

Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management
por: Simonetti, Oriana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9umvn09qq75rg355ppo8l0m59d